FTC fights against new strategy for delaying generics   Leave a comment

NORWICH, CT - MARCH 23: Oxycodone pain pills prescribed for a patient with chronic pain lie on display on March 23, 2016 in Norwich, CT. Communities nationwide are struggling with the unprecidented opioid pain pill and heroin addiction epidemic. On March 15, the U.S. Centers for Disease Control (CDC), announced guidelines for doctors to reduce the amount of opioid painkillers prescribed, in an effort to curb the epidemic. The CDC estimates that most new heroin addicts first became hooked on prescription pain medication before graduating to heroin, which is stronger and cheaper. (Photo by John Moore/Getty Images)

Link: http://www.marketplace.org/2016/03/31/health-care/ftc-fights-against-new-strategy-delaying-generics

Summary: The Federal Trade Commission (FTC) has brought an important case against ‘pay-for-delay schemes’, seeking to show that non-monetary deals between pharmaceutical companies inhibit the market from functioning properly. More importantly, they seek to demonstrate that these deals are illegal.

Original Air Date: April 1, 2016

Length: 2 minutes 10 seconds

Posted September 14, 2016 by cherokeebelval in Ethics, Government, Health economics, Market structure, Monopoly, Perfect competition, Regulation, short length

Tagged with , ,

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

%d bloggers like this: